Barclays Gains Ahead of Key Earnings and Strategic Update
Earnings James Calloway

Barclays Gains Ahead of Key Earnings and Strategic Update

Barclays shares rose 2.71% to 479.1 pence on Friday, setting a positive tone before the bank's full-year results and strategic targets announcement on Tuesday. Investors are focused on cost management, credit quality, and capital returns.

BCS
Rolls-Royce Shares Gain on Buyback Activity Ahead of Key Results
Markets Daniel Marsh

Rolls-Royce Shares Gain on Buyback Activity Ahead of Key Results

Rolls-Royce Holdings shares advanced 1.78% to 1,229p Friday, buoyed by ongoing share repurchases and defense sector engagement. Investors await full-year results later this month.

RYCEY
Vodafone Launches Share Buyback Amid Focus on German Market Turnaround
Markets Daniel Marsh

Vodafone Launches Share Buyback Amid Focus on German Market Turnaround

Vodafone has initiated a £29.4 million share repurchase program while investors monitor Germany's service revenue growth. The telecom giant reported 5.4% group service revenue expansion in Q3.

VOD
NatWest Nears Major £2.5bn Wealth Management Acquisition
Markets Daniel Marsh

NatWest Nears Major £2.5bn Wealth Management Acquisition

NatWest Group is reportedly close to finalizing a £2.5-2.7 billion takeover of Evelyn Partners, potentially announcing the deal as early as Monday.

BCS XLF
Experian Shares Tumble Near 52-Week Low Amid AI Concerns and Buyback Activity
Markets Daniel Marsh

Experian Shares Tumble Near 52-Week Low Amid AI Concerns and Buyback Activity

Experian stock fell 4.65% to 2,499 pence on Friday, approaching a 52-week low, as the company continued its $1 billion share repurchase program. Investors are eyeing upcoming U.S. inflation data and peer earnings for direction.

EFX
Lloyds Share Buyback and Housing Data Set Tone for UK Banking Week
Markets Daniel Marsh

Lloyds Share Buyback and Housing Data Set Tone for UK Banking Week

Lloyds Banking Group executed a 10 million share repurchase as its Halifax unit reported a 0.7% monthly rise in UK house prices. Investors are monitoring mortgage trends and upcoming sector news.

LYG
Unilever Awaits Key Post-Demerger Results as Shares Hold Steady
Earnings James Calloway

Unilever Awaits Key Post-Demerger Results as Shares Hold Steady

Unilever shares closed flat at 5,250 pence ahead of its first full-year report since spinning off its ice cream division. Investors await clarity on 2026 sales growth and margin outlook.

UL
Microsoft to Halt New Legacy Printer Driver Updates for Windows 11 in 2026
Technology Sarah Chen

Microsoft to Halt New Legacy Printer Driver Updates for Windows 11 in 2026

Microsoft will cease publishing new third-party V3/V4 printer drivers to Windows Update for Windows 11 and Windows Server 2025+ starting January 15, 2026, as part of a shift to a modern print platform.

MSFT
Reckitt Announces £1.6 Billion Special Dividend Ahead of Key Investor Events
Earnings James Calloway

Reckitt Announces £1.6 Billion Special Dividend Ahead of Key Investor Events

Reckitt Benckiser shares hold near 52-week highs as the company prepares to distribute a £1.6 billion special dividend on February 20, with management set to present at the CAGNY conference on February 19.

RKT
LSEG Stock Slumps as AI Concerns Weigh on Data Sector
Markets Daniel Marsh

LSEG Stock Slumps as AI Concerns Weigh on Data Sector

London Stock Exchange Group shares fell for a third consecutive week, dropping 8%, amid renewed investor anxiety over AI disruption to data and analytics firms.

LSE
Anglo American Downgraded by BofA Amid De Beers Uncertainty, Shares Dip
Analysis Daniel Marsh

Anglo American Downgraded by BofA Amid De Beers Uncertainty, Shares Dip

Anglo American shares fell 0.75% to 3,435p after BofA downgraded the stock to 'neutral', citing valuation concerns and execution risks ahead of key updates.

NGLOY
GSK Gains EU Approval for Nucala in COPD, Stock Momentum in Focus
Regulation James Calloway

GSK Gains EU Approval for Nucala in COPD, Stock Momentum in Focus

GSK shares rose after EU regulators approved expanded use of Nucala for chronic obstructive pulmonary disease. The stock has surged 17% this week and nearly 49% over the past year.

GSK